{"id":58,"date":"2017-03-15T21:22:05","date_gmt":"2017-03-15T21:22:05","guid":{"rendered":"http:\/\/34.138.3.201\/?page_id=58"},"modified":"2020-05-08T09:37:56","modified_gmt":"2020-05-08T09:37:56","slug":"alzheimers-disease-research-unit","status":"publish","type":"page","link":"https:\/\/mcsa.ca\/index.php\/alzheimers-disease-research-unit\/","title":{"rendered":"Alzheimer’s Disease Research Unit"},"content":{"rendered":"

Director: Dr. Serge Gauthier, C.M., C.Q., MD, FRCPC<\/strong><\/p>\n

\"\"<\/p>\n

Alzheimer\u2019s disease (AD) is the most common type of dementia worldwide.<\/p>\n

The incidence and prevalence of AD increases with age. It is estimated that more people will be affected by this condition, due to the increasing longevity of our population.<\/p>\n

The Alzheimer and Cognitive Disorders Clinic, a division of the McGill University Research Centre for Studies in Aging<\/strong>, was founded in 1997 to establish a clinic that specializes in AD and related disorders.<\/p>\n

The Clinic\u2019s primary focus is to seek improved therapies, both symptomatic and preventive, for AD and cognitive disorders; to ensure long-term stabilization for patients; and to enhance the quality of life for patients and caregivers.<\/p>\n

The Clinic offers expertise in the early diagnosis and management of AD and cognitive disorders, including vascular dementia and mild cognitive impairment.<\/p>\n

Evaluation, treatment, and follow-up are available, as well as referral to other resources, such as help and support services, if desired.<\/p>\n

The Clinic is actively involved in cognitive research and is recognized internationally as a clinical trial site. Clinical trials (Phases II-IV) that test the efficacy and safety of experimental drugs for AD and other cognitive disorders are ongoing.<\/p>\n

Dr. Serge Gauthier, C.M., C.Q., MD, FRCPC<\/strong>,<\/strong> neurologist, and specialist in the field, leads a team of experienced and dedicated health professionals. Evaluations are carried out in a friendly and inviting atmosphere at a location which is easily accessible.<\/p>\n

Further Information<\/strong><\/p>\n

For an appointment with the following doctors:<\/p>\n\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t
\"\"<\/td>

Dr. Serge Gauthier, C.M., C.Q., MD, FRCPC<\/h4><\/td>\n<\/tr>\n

\"\"<\/td>

Dr. Pedro Rosa-Neto, MD, PhD<\/h4><\/td>\n<\/tr>\n

\"\"<\/td>

Dr. Paolo Vitali, MD, PhD, FRCPC<\/h4><\/td>\n<\/tr>\n

\"\"<\/td>

St\u00e9phane Ledoux, MD<\/h4>
\nNeurologist, Alzheimer Disease Research Unit
\nMcGill University Research Centre for Studies in Aging
\nEmail: ledouxs@videotron.ca
\n<\/td>\n<\/tr>\n

\"\"<\/td>

Simon Ducharme, MD, MSc, FRCP(C)<\/h4>
\nNeuropsychiatrist, Alzheimer Disease Research Unit
\nMcGill University Research Centre for Studies in Aging
\nEmail: simon.ducharme@mcgill.ca
\n<\/td>\n<\/tr>\n

\"\"<\/td>Dr. Maiya R. Geddes<\/b>, MD, FRCPC
\nBehavioural Neurologist, Alzheimer Disease Research Unit
\nAt the McGill University Research Center for Studies in Aging, Dr. Geddes sees patients in behavioural neurology and leads a research lab at the The Montreal Neurological Institute & Hospital. The focus of Dr.\u00a0Geddes' research is to understand the interaction between motivation and cognition in\u00a0human aging.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n

Please send your consultation request by fax, email or mail to the following address:
\nMcGill University Research Centre for Studies in Aging
\n6825 LaSalle Boulevard
\nVerdun (QC) H4H 1R3<\/p>\n

Telephone: 514-766-2010 – Fax: 514-888-4050<\/p>\n

E-mail: info.mcsa@mcgill.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Director: Dr. Serge Gauthier, C.M., C.Q., MD, FRCPC Alzheimer\u2019s disease (AD) is the most common type of dementia worldwide. The incidence and prevalence of AD increases with age. It is estimated that more people will be affected by this condition, due to the increasing longevity of our population. The Alzheimer and Cognitive Disorders Clinic, a […]<\/p>\n","protected":false},"author":6,"featured_media":501,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/58"}],"collection":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/comments?post=58"}],"version-history":[{"count":6,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/58\/revisions"}],"predecessor-version":[{"id":1148,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/58\/revisions\/1148"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/media\/501"}],"wp:attachment":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/media?parent=58"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}